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CORRESPONDENCE 
Sudden cardiac death is associated both with epilepsy and with use of antiepileptic drugs  
To the Editor, We read with interest the recent paper by Bardai et al,1 which reports that epilepsy 
and antiepileptic drugs (AEDs) were independently associated with sudden cardiac death (SCD). We 
are unconvinced that such a clear distinction between disease and drug effects can be made in this 
study as all people with epilepsy were by definition taking AEDs. We believe this is why SCD risk in 
those with epilepsy (table 2) and in AED users with epilepsy (table 3) was the same: OR 2.8 (95% CI 
1.4 to 5.3). It is unclear whether these numbers reflect disease effects, drug effects or both. It is 
reported that people with epilepsy are at increased risk of SCD, yet in this population there is a major 
diagnostic alternative: sudden unexpected death in epilepsy, an autopsy-negative mostly seizure-
related type of sudden death with cardiac and noncardiac causes.2 We do not believe that sudden 
death in people with epilepsy can be assumed to be of cardiac origin (vs, for example neurogenic 
respiratory depression) without documentation of a cardiac mechanism of death (eg, by ECG). 
Carbamazepine and gabapentin were the only individual AEDs associated with increased SCD risk. 
The authors attribute this to the supposed sodium channel blocking properties of these drugs, but 
we believe that indication bias cannot be excluded. Carbamazepine is the drug of choice in people 
with focal seizures and stroke is a leading cause of this type of epilepsy, particularly in the elderly.3 
An important indication for gabapentin is diabetic chronic neuropathic pain.4 It is possible that a 
worse cardiovascular status rather than sodium channel blocking properties explains the higher SCD 
risk in users of these AEDs. Despite the use of a large database, many numbers are small, so the 
demonstrated significant effect for sodium channel blocking AEDs but not for nonsodium channel 
blocking AEDs may reflect limited sample size rather than differences in effect. There was a 
consistent trend; all reported AED ORs were greater than the null value. This paper is important in 
that it confirms that epilepsy in the community is associated with an increased risk of sudden natural 
death. Future studies with additional documentation of death mechanisms, correction for indication 
bias and larger sample size are needed to explain the cause of this excess risk and clarify the role of 
AEDs. 
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